Telehealth: conducting medication reviews during COVID-19

What do pharmacists need to know about the recent ‘telepharmacy’ changes? The COVID-19 pandemic has changed the face of healthcare – and indeed pharmacy – as we know it.  Since 21 April, pharmacists have been able to undertake a range of medication reviews via telehealth, including MedsChecks, Diabetes MedsChecks, Home Medicines Reviews and Residential Medication Management Reviews for eligible patients, according to changes enacted by the Federal government.  The ‘telepharmacy’ measures were announced following the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘Who takes responsibility for errors?’
Next 5 questions about pharmacy employee rights